A detailed history of Wells Fargo & Company transactions in Fibrogen Inc stock. As of the latest transaction made, Wells Fargo & Company holds 10,000 shares of FGEN stock, worth $4,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares
10,000
Previous 10,000 -0.0%
Holding current value
$4,000
Previous $8,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$0.89 - $2.36 $20,487 - $54,327
-23,020 Reduced 69.72%
10,000 $8,000
Q1 2024

May 10, 2024

SELL
$0.73 - $2.73 $908 - $3,398
-1,245 Reduced 3.63%
33,020 $77,000
Q4 2023

Feb 09, 2024

BUY
$0.38 - $0.91 $4,303 - $10,304
11,324 Added 49.36%
34,265 $30,000
Q3 2023

Nov 13, 2023

SELL
$0.79 - $2.83 $77,851 - $278,885
-98,546 Reduced 81.12%
22,941 $19,000
Q2 2023

Aug 15, 2023

BUY
$2.49 - $20.59 $77,267 - $638,928
31,031 Added 34.31%
121,487 $328,000
Q1 2023

May 12, 2023

BUY
$15.95 - $25.18 $1.05 Million - $1.67 Million
66,127 Added 271.8%
90,456 $1.69 Million
Q4 2022

Feb 13, 2023

BUY
$13.27 - $17.73 $268,558 - $358,819
20,238 Added 494.7%
24,329 $389,000
Q3 2022

Nov 14, 2022

SELL
$11.4 - $14.6 $9,405 - $12,045
-825 Reduced 16.78%
4,091 $54,000
Q2 2022

Aug 12, 2022

SELL
$7.94 - $12.96 $338,918 - $553,197
-42,685 Reduced 89.67%
4,916 $51,000
Q1 2022

May 16, 2022

SELL
$12.02 - $16.79 $321,306 - $448,813
-26,731 Reduced 35.96%
47,601 $572,000
Q4 2021

Feb 14, 2022

SELL
$9.93 - $15.39 $191,271 - $296,442
-19,262 Reduced 20.58%
74,332 $1.05 Million
Q3 2021

Nov 15, 2021

SELL
$10.18 - $26.64 $171,186 - $447,978
-16,816 Reduced 15.23%
93,594 $957,000
Q2 2021

Aug 16, 2021

SELL
$18.57 - $35.68 $796,690 - $1.53 Million
-42,902 Reduced 27.98%
110,410 $2.94 Million
Q1 2021

May 13, 2021

SELL
$31.0 - $55.72 $91,729 - $164,875
-2,959 Reduced 1.89%
153,312 $5.32 Million
Q4 2020

Feb 09, 2021

SELL
$37.09 - $48.97 $563,322 - $743,756
-15,188 Reduced 8.86%
156,271 $5.8 Million
Q3 2020

Nov 05, 2020

BUY
$40.47 - $45.5 $612,108 - $688,187
15,125 Added 9.67%
171,459 $7.05 Million
Q2 2020

Aug 13, 2020

BUY
$32.57 - $42.83 $701,199 - $922,087
21,529 Added 15.97%
156,334 $6.34 Million
Q1 2020

May 14, 2020

BUY
$23.3 - $45.96 $3.14 Million - $6.2 Million
134,805 New
134,805 $4.69 Million

Others Institutions Holding FGEN

About FIBROGEN INC


  • Ticker FGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 93,741,200
  • Market Cap $37.5M
  • Description
  • FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...
More about FGEN
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.